title: Metoclopramide, an increasingly recognized cause of tardive dyskinesia.
authors.affiliation: Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Houston, TX 77030, USA.
authors.forename: Christopher
authors.initials: C
authors.lastname: Kenney
authors.forename: Christine
authors.initials: C
authors.lastname: Hunter
authors.forename: Anthony
authors.initials: A
authors.lastname: Davidson
authors.forename: Joseph
authors.initials: J
authors.lastname: Jankovic
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000706:statistics & numerical data*; D000368:Aged; D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology / Q000209:etiology*; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D010546:Perphenazine / Q000009:adverse effects / Q000627:therapeutic use; D012189:Retrospective Studies; D013781:Texas / Q000453:epidemiology; D013881:Thioridazine / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000639:Amitriptyline; D010546:Perphenazine; D006220:Haloperidol; D008787:Metoclopramide; D013881:Thioridazine